Razelle Kurzrock, Chief Medical Officer of the WIN Consortium and Director of the Center for Precision Oncology and Rare Cancers at the Medical College of Wisconsin, shared on X:
“Hot off the press.
Immunotherapy Efficacy in SMARC-Altered Cancers: A pan-cancer analysis of clinical outcomes in response to immune checkpoint inhibition.”
Title: Immunotherapy Efficacy in SMARC-Altered Cancers: A pan-cancer analysis of clinical outcomes in response to immune checkpoint inhibition
Authors: Gregory P. Botta, Wesleigh Edwards, Daisuke Nishizaki, Diana C. Hargreaves, Shumei Kato, Razelle Kurzrock
Read The Full Article
